PepGen (PEPG) Current Taxes (2022 - 2023)
PepGen (PEPG) reported Current Taxes of $3.4 million for Q2 2023, down 15.62% on a YoY basis from $4.0 million in Q2 2022, and up 1.11% sequentially from $3.3 million in Q1 2023.
PepGen (PEPG) Current Taxes (2022 - 2023) Analysis & Trends
PepGen (PEPG) has 2 years of Current Taxes data on file, last reported at $3.4 million in Q2 2023.
- For the quarter ending Q2 2023, Current Taxes fell 15.62% year-over-year to $3.4 million; the trailing twelve-month figure through Jun 2023 stood at $3.4 million (down 15.62% YoY), and the FY2022 full-year result was $2.6 million, changed N/A from the prior year.
- Current Taxes improved to $3.4 million in Q2 2023, from $3.3 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $4.3 million in Q1 2022 to a low of $2.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 63.52 Mn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | PepGen | 133.69 Mn | 133.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 3.34 Mn |
| Dec 31, 2022 | 2.57 Mn |
| Sep 30, 2022 | 3.67 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 4.33 Mn |